Clinical Trial: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Sponsor and Collaborators
Therapeutic Advances in Childhood Leukemia Consortium
Enzon Pharmaceuticals, Inc.

Contact
Contact: Jeannette van der Giessen, BA
323-361-8725
[email protected]


Continue Reading

Contact: Elena Eckroth
323-361-5429
[email protected]

Principal Investigator
Study Chair: Elizabeth Raetz, MD New York University Medical Center
Study Chair: William Carroll, MD New York University Medical Center

ClinicalTrials.gov Identifier
NCT01186328